Endocrine therapy

Trying to change the course of breast cancer treatment around the world

Mater breast tumour pathologist, Dr Cameron Snell, is currently doing research which could hold the key to improving treatment therapies for women with late stage breast cancer. 

Currently, all patients that have positive estrogen receptor forms of breast cancer—found in approximately 75 per cent of all breast cancer patients—are treated with hormonal therapy. However, only half of these patients will respond to the therapy. These women currently have to undergo treatment, and its subsequent side effects—such as hot nausea, headaches, joint pain and stiffness, hot flushes and mood changes—before waiting to see how their cancer responds.

Dr Snell hopes to develop a test which will identify which women will respond positively to hormone therapy. This will enable clinicians to rapidly personalise treatment plans for each breast cancer patient. 

Dr Snell’s research is extremely promising and has the potential to change the course of breast cancer treatment for women not just at Mater, but around the world. 

These new developments in the breast cancer research space simply would not have been possible without the support of people like you.


Mater Chicks in Pink

By supporting Mater Chicks in Pink you'll be making an immediate impact on women being treated for breast cancer at Mater, by funding tangible and timely support services like counselling and mastectomy bras—at a time when they need it most. Your funds will also support the work of researchers at Mater Research, who are working on the causes of, and developing potentially life-saving treatment for breast cancer.